humulene has been researched along with Dermatitis--Atopic* in 6 studies
2 review(s) available for humulene and Dermatitis--Atopic
Article | Year |
---|---|
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity.
Diet has long been understood to have an intricate association with atopic dermatitis, although much remains unelucidated. Skin barrier dysfunction with dysbiosis and consequent impairment of immune tolerance likely underly the pathogenesis of coincident atopic dermatitis and food allergy. There is a wide range of possible skin reactions to food, complicating the diagnosis and understanding of food allergies. Many patients, parents, and providers incorrectly suspect diet as causative of atopic dermatitis symptoms and many have tried elimination diets. This frequently leads to inaccurate labeling of food allergies, contributing to a dangerous spiral of inappropriate testing, referrals, and dietary changes, while neglecting established atopic dermatitis treatment essentials. Alternatively, certain dietary supplements or the introduction of certain foods may be beneficial for atopic dermatitis management or prevention. Greater consensus on the role of diet among providers of patients with atopic dermatitis is strongly encouraged to improve the management of atopic dermatitis. Topics: Allergens; Cannabis; Dermatitis, Atopic; Diet; Dietary Supplements; Dysbiosis; Epithelium; Food Hypersensitivity; Histidine; Humans; Plant Extracts; Practice Guidelines as Topic; Tea | 2022 |
The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020.
The human endocannabinoid system (ECS) is a complex signalling network involved in many key physiological processes. The ECS includes the cannabinoid receptors, the endocannabinoid ligands, and the enzymes related to their synthesis and degradation. Other cannabinoids encompass the phytocannabinoids from Cannabis sativaL.(marijuana) and the synthetic cannabinoids. Alterations in the ECS are associated with different diseases, including inflammatory and immune-mediated disorders such as allergy. Allergy is a global health problem of increasing prevalence with high socio-economic impact. Different studies have convincingly demonstrated that cannabinoids play a role in allergy, but their actual contribution is still controversial. It has been shown that cannabinoids exert anti-inflammatory properties in the airways and the skin of allergic patients. Other studies reported that cannabinoids might exacerbate asthma and atopic dermatitis mainly depending on CB2-mediated signalling pathways. A better understanding of the molecular mechanisms involved in the mode of action of specific cannabinoids and cannabinoid receptors on relevant immune cells under different biological contexts might well contribute to the design of novel strategies for the prevention and treatment of allergic diseases. Future research in this promising emerging field in the context of allergy is warranted for the upcoming years. Topics: Animals; Asthma; Cannabinoids; Cannabis; Dermatitis, Atopic; Endocannabinoids; Humans; Hypersensitivity; Immunomodulation; Immunosuppression Therapy | 2020 |
1 trial(s) available for humulene and Dermatitis--Atopic
Article | Year |
---|---|
Efficacy of dietary hempseed oil in patients with atopic dermatitis.
Hempseed oil is a rich and balanced source of omega-6 and omega-3 polyunsaturated fatty acids (PUFAs). Anecdotal evidence indicated that dietary hempseed oil might be useful in treating symptoms of atopic dermatitis.. Dietary hempseed oil and olive oil were compared in a 20-week randomized, single-blind crossover study with atopic patients. Fatty acid profiles were measured in plasma triglyceride, cholesteryl and phospholipid fractions. A patient questionnaire provided additional information on skin dryness, itchiness and usage of dermal medications. Skin transepidermal water loss (TEWL) was also measured.. Levels of both essential fatty acids (EFAs), linoleic acid (18:2n6) and alpha-linolenic acid (18:3n3), and gamma-linolenic acid (GLA; 18:3n6) increased in all lipid fractions after hempseed oil, with no significant increases of arachidonic acid (20:4n6) in any lipid fractions after either oil. Intra-group TEWL values decreased (p=0.074), qualities of both skin dryness and itchiness improved (p=0.027) and dermal medication usage decreased (p=0.024) after hempseed oil intervention.. Dietary hempseed oil caused significant changes in plasma fatty acid profiles and improved clinical symptoms of atopic dermatitis. It is suggested that these improvements resulted from the balanced and abundant supply of PUFAs in this hempseed oil. Topics: Adult; Cannabis; Cross-Over Studies; Dermatitis, Atopic; Dietary Fats, Unsaturated; Fatty Acids, Essential; Female; Humans; Lipids; Male; Middle Aged; Olive Oil; Plant Oils; Single-Blind Method; Water Loss, Insensible | 2005 |
3 other study(ies) available for humulene and Dermatitis--Atopic
Article | Year |
---|---|
Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.
We aimed to examine the effects of cannabidiol (CBD)-containing hemp oil without delta-9-tetrahydrocannabinol (THC) as a supplemental treatment for canine atopic dermatitis (CAD), as well as its adverse effects, and effects on concurrent drug use in dogs.. In this retrospective case series, 8 dogs with CAD were diagnosed by veterinary dermatologists certified by the Japanese Society of Veterinary Dermatology.. The medical records of dogs supplemented with CBD-containing hemp oil were evaluated with respect to signalment, physical examination, plasma C-reactive protein concentrations, pharmacologic management, the CAD Extent and Severity Index (4th iteration), and the Pruritus Visual Analog Scale.. Overall, CBD, used as a supplement in combination with other drugs, was well-tolerated over a wide dose range and decreased the occurrence of pruritus in dogs with CAD when ingested twice a day.. This study provides the first report of supplementation with CBD without THC that was effective in controlling pruritic behavior in dogs with CAD.. Further controlled studies are required to investigate the dose range, efficacy, and safety.. Effets du cannabidiol sans delta-9-tétrahydrocannabinol sur la dermatite atopique canine : évaluation rétrospective de huit cas.. Nous avons cherché à examiner les effets de l’huile de chanvre contenant du cannabidiol (CBD) sans delta-9-tétrahydrocannabinol (THC) en tant que traitement complémentaire de la dermatite atopique canine (CAD), ainsi que ses effets indésirables et ses effets sur les médicaments concomitants utilisés chez le chien.. Dans cette étude rétrospective de cas, huit chiens atteints de CAD ont été diagnostiqués par des dermatologues vétérinaires certifiés par la Société japonaise de dermatologie vétérinaire.. Les dossiers médicaux des chiens supplémentés avec de l’huile de chanvre contenant du CBD ont été évalués en ce qui concerne le signalement, l’examen physique, les concentrations plasmatiques de protéine C-réactive, la gestion pharmacologique, l’indice. Dans l’ensemble, le CBD, utilisé comme supplément en association avec d’autres médicaments, a été bien toléré sur une large gamme de doses et a diminué l’apparition de prurit chez les chiens atteints de CAD lorsqu’il est ingéré deux fois par jour.. Cette étude fournit le premier rapport de supplémentation en CBD sans THC efficace pour contrôler le comportement prurigineux chez les chiens atteints de CAD.. D’autres études contrôlées sont nécessaires pour étudier la gamme de doses, l’efficacité et l’innocuité.(Traduit par D Topics: Animals; Cannabidiol; Cannabis; Dermatitis, Atopic; Dog Diseases; Dogs; Dronabinol; Plant Extracts; Retrospective Studies | 2022 |
Allergic inhalant dermatitis attributable to marijuana exposure in a dog.
Exposure to marijuana was believed to be responsible for clinical signs consistent with allergic inhalant dermatitis in a dog. The dog had facial and pedal pruritus associated with bilateral ocular discharge. Clinical signs resolved when the dog was kenneled, but returned when the dog was returned to its home. The results of intradermal skin testing, using a standard tray of 51 inhalant extracts, did not adequately account for the dog's clinical signs. Later, the owners indicated that previous residents of the owners' home had cultivated marijuana intensively inside and outside of the home. Intradermal skin testing with a source of marijuana pollen extract was performed, yielding a positive reaction in the dog and a negative reaction in another dog without clinical or historical evidence of allergic inhalant dermatitis. The affected dog was treated successfully and exclusively by hyposensitization with marijuana pollen extract. Topics: Animals; Cannabis; Dermatitis, Atopic; Desensitization, Immunologic; Dog Diseases; Dogs; Intradermal Tests; Male; Pollen | 1989 |
[GENERAL TOXICODERMATITIS FOLLOWING ACUTE POISONING CAUSED BY SMOKING INDIAN HEMP].
Topics: Cannabis; Dermatitis; Dermatitis, Atopic; Hypersensitivity, Immediate; Immune System Diseases; Smoking; Toxicology | 1964 |